TECENTRIQ
Google image searchProduct monograph
Active ingredient
atezolizumab, 840 MG/14 ML
DIN: 02492393
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: CONCENTRATE. SINGLE USE VIALS.
Schedule: Prescription / Schedule D
Company: HOFFMANN-LA ROCHE LIMITED
Date: 16-OCT-2019
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FF — PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (ATC, ATC/DDD)
- L01FF05 — ATEZOLIZUMAB (ATC/DDD)
External Links for Tecentriq
Search on Google
Hoffmann-La Roche Limited
Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find tecentriq photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.